Skip to main content
. 2020 Nov 4;27(8):1294–1301. doi: 10.1093/ibd/izaa282

FIGURE 2.

FIGURE 2.

Kaplan-Meier analysis of time to new biologic therapy after ustekinumab dose intensification. *Calculated using log-rank test. Numbers represent censoring at loss of follow-up, time of ustekinumab discontinuation without initiation of new biologic therapy, or time of further ustekinumab dose intensification from every 6 weeks to every 4 weeks.